Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases (including Covid-19) and rare cancers. In clinical research, Cepharanthine exhibits multiple pharmacological effects, including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions.


CSE:PHRX - Post by User

Post by cisco3on Dec 17, 2020 2:50pm
46 Views
Post# 32130006

flight1000 check ID.vn cheapest BTC/BC play

flight1000 check ID.vn cheapest BTC/BC play

Identillect advances Blockchain to ensure the greatest protection for New European and Canadian Regulations

Identillect advances security to help businesses comply with regulatory changes for data handling regulations across Europe

Source: Identillect Technologies Corp.
 
 

IRVINE, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Identillect Technologies Corp. (the "Company" or "Identillect") (TSX-V:ID) (OTCQB:IDTLF) (Frankfurt:8ID) – announces the Company advances its blockchain technology to handle the pending demand from the new European data handling regulation, General Data Protection Regulation (GDPR). This regulation is pervasive across all of Europe and affects companies in the United States and Canada that do business in Europe.  The regulation becomes active in May 2018 and is one of the strictest data handling regulations ever written requiring companies to protect customer information.

As regulations advance across Europe, the development of security technology is critical for businesses to comply with the GDPR. Identillect has continued to advance technology and works to progress partnerships to make Delivery Trust® a top selected product when businesses are looking to meet GDPR requirements.  Blockchain has been recognized as a technology which is sought after to assist businesses to meet and exceed GDPR regulations. Identillect has made recent developments with blockchain technology to enable companies across Europe to meet GDPR regulations which will imminently affect businesses.


<< Previous
Bullboard Posts
Next >>